Next-next generation sequencing: Personalized medicine in hereditary cancer

(IDIBELL-Bellvitge Biomedical Research Institute) Five leading research institutions (IDIBELL, Hospital del Mar, Irsicaixa, VHIO and VHIR) create the 'Next-Next Generation Sequencing' Platform, together with Roche Diagnostics, to develop diagnostic applications of cancer and infectious diseases